(2) Ensuring the availability and retention of pertinent records.
Before the receiving IRB accepts oversight of the transferred clinical investigation, it should
obtain copies of pertinent records to allow it to meet its review and ongoing oversight
responsibilities for the study once transferred.
11
Pertinent records include documents such as the
research protocol and significant amendments; approved consent form; investigator’s brochure;
minutes of IRB meetings at which the research was reviewed; reports of unanticipated problems
involving risk to human subjects and others; reports of IRB-conducted audits, if any; and
correspondence with the investigator, sponsor, and/or FDA.
Dostları ilə paylaş: |